Literature DB >> 16354848

The effects of pulmonary rehabilitation in the national emphysema treatment trial.

Andrew L Ries1, Barry J Make, Shing M Lee, Mark J Krasna, Matthew Bartels, Rebecca Crouch, Alfred P Fishman.   

Abstract

STUDY
OBJECTIVES: Pulmonary rehabilitation is an established treatment in patients with chronic lung disease but is not widely utilized. Most trials have been conducted in single centers. The National Emphysema Treatment Trial (NETT) provided an opportunity to evaluate pulmonary rehabilitation in a large cohort of patients who were treated in centers throughout the United States.
DESIGN: Prospective observational study of cohort prior to randomization in a multicenter clinical trial.
SETTING: University-based clinical centers and community-based satellite pulmonary rehabilitation programs. PATIENTS AND INTERVENTION: A total of 1,218 patients with severe emphysema underwent pulmonary rehabilitation before and after randomization to lung volume reduction surgery (LVRS) or continued medical management. Rehabilitation was conducted at 17 NETT centers supplemented by 539 satellite centers. MEASUREMENTS AND
RESULTS: Lung function, exercise tolerance, dyspnea, and quality of life were evaluated at regular intervals. Significant (p < 0.001) improvements were observed consistently in exercise (cycle ergometry, 3.1 W; 6-min walk test distance, 76 feet), dyspnea (University of California, San Diego Shortness of Breath Questionnaire score, -3.2; Borg breathlessness score: breathing cycle, -0.8; 6-min walk, -0.5) and quality of life (St. George Respiratory Questionnaire score, -3.5; Quality of Well-Being Scale score, +0.035; Medical Outcomes Study 36-item short form score: physical health summary, +1.3; mental health summary, + 2.0). Patients who had not undergone prior rehabilitation improved more than those who had. In multivariate models, only prior rehabilitation status predicted changes after rehabilitation. In 20% of patients, exercise level changed sufficiently after rehabilitation to alter the NETT subgroup predictive of outcome. Overall, changes after rehabilitation did not predict differential mortality or improvement in exercise (primary outcomes) by treatment group.
CONCLUSIONS: The NETT experience demonstrates the effectiveness of pulmonary rehabilitation in patients with severe emphysema who were treated in a national cross-section of programs. Pulmonary rehabilitation plays an important role in preparing and selecting patients for surgical interventions such as LVRS.

Entities:  

Mesh:

Year:  2005        PMID: 16354848     DOI: 10.1378/chest.128.6.3799

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  39 in total

1.  Exercise performance after standard rehabilitation in COPD patients with lung hyperinflation.

Authors:  Ernesto Crisafulli; Elena Venturelli; Gianluca Biscione; Guido Vagheggini; Andrea Iattoni; Sasha Lucic; Nicolino Ambrosino; Franco Pasqua; Alfredo Cesario; Enrico Maria Clini
Journal:  Intern Emerg Med       Date:  2011-11-22       Impact factor: 3.397

2.  Pulmonary rehabilitation for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.

Authors:  Jerry Tran; Emily E Norder; Philip T Diaz; Gary S Phillips; Pat Elder; Steven M Devine; Karen L Wood
Journal:  Biol Blood Marrow Transplant       Date:  2012-01-30       Impact factor: 5.742

3.  Caring for the burden of COPD.

Authors:  P M A Calverley
Journal:  Thorax       Date:  2006-10       Impact factor: 9.139

4.  Worse Prognosis for Stage IA Lung Cancer Patients with Smoking History and More Severe Chronic Obstructive Pulmonary Disease.

Authors:  Yukihiro Yoshida; Hidenori Kage; Tomohiro Murakawa; Yasunori Sato; Satoshi Ota; Masashi Fukayama; Jun Nakajima
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-01-26       Impact factor: 1.520

5.  Six-minute-walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of Global Initiative for Chronic Obstructive Lung Disease 2011 Group.

Authors:  Michael T Durheim; Patrick J Smith; Michael A Babyak; Stephanie K Mabe; Tereza Martinu; Karen E Welty-Wolf; Charles F Emery; Scott M Palmer; James A Blumenthal
Journal:  Ann Am Thorac Soc       Date:  2015-03

6.  Multivariate models of determinants of health-related quality of life in severe chronic obstructive pulmonary disease.

Authors:  Marilyn L Moy; John J Reilly; Andrew L Ries; Zab Mosenifar; Robert M Kaplan; Robert Lew; Eric Garshick
Journal:  J Rehabil Res Dev       Date:  2009

Review 7.  The evaluation and preparation of the patient for lung volume reduction surgery.

Authors:  Malcolm M DeCamp; David Lipson; Mark Krasna; Omar A Minai; Robert J McKenna; Byron M Thomashow
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 8.  Pulmonary rehabilitation in emphysema.

Authors:  Andrew L Ries; Barry J Make; John J Reilly
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 9.  A clinician's guide to the use of lung volume reduction surgery.

Authors:  Gerard J Criner; Alice L Sternberg
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

10.  Assessment of a primary and tertiary care integrated management model for chronic obstructive pulmonary disease.

Authors:  Ignasi Bolíbar; Vicente Plaza; Mariantònia Llauger; Ester Amado; Pedro A Antón; Ana Espinosa; Leandra Domínguez; Mar Fraga; Montserrat Freixas; Josep A de la Fuente; Iskra Liguerre; Casimira Medrano; Meritxell Peiro; Mariantònia Pou; Joaquin Sanchis; Ingrid Solanes; Carles Valero; Pepi Valverde
Journal:  BMC Public Health       Date:  2009-02-24       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.